In the latest issue of Forbes magazine, John LaMatinna, former president of Phizer R&D and a Forbes contributor, writes about apparent conflicts of interest in some drug TV ads, and the understated reality that nobody really needs to hear more about erectile dysfunction while watching the evening news.

We all know that there is big money in TV advertising and even bigger money in successful drug sales.  To have a former insider who is now on the outside question whether these Pharma ads really serve any useful purpose is refreshing.  It’s worth a quick read.